EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Prognostic impact of pretreatment cell‐free DNA concentration in newly diagnosed peripheral T‐cell lymphomas

E Fardella iD, G Zanirato, M Magni, N Caldarelli, A Chiappella iD, A Dodero, S Ljevar, L Orsucci, A Re, S V Usai, V Stefoni, C Castellino und 4 weitere

British Journal of Haematology · 2024

DOI: 10.1111/bjh.19280 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift British Journal of Haematology, 2024. Verfasst von E Fardella und 15 weiteren Autor:innen. Beteiligte Einrichtung: University of Milan, Milan, Italy. Hauptthemen laut MEDLINE: Lymphoma, T-Cell, Peripheral, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Associazione Italiana per la Ricerca sul Cancro, Associazione Italiana Contro le Leucemie - Linfomi e Mieloma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peripheral T‐cell lymphomas (PTCLs) have a poor prognosis and, to date, there are no reliable predictive biomarkers of response. In this work we explored the prognostic impact of cell‐free DNA (cfDNA) concentration in 75 newly diagnosed patients enrolled in a prospective multicenter study. Pre‐treatment cfDNA was strongly associated with clinical risk factors and was identified as a superior predictor for shorter progression‐free survival in multivariable analysis, outweighing canonical risk parameters. Furthermore, we identified a cfDNA value above which survival worsens. In conclusion, pre‐treatment cfDNA concentration represents an easily usable predictive biomarker that is highly associated with survival of PTCL patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, T-Cell, PeripheralCell-Free Nucleic AcidsHumansMaleFemaleMiddle AgedAgedPrognosisAdultBiomarkers, TumorProspective StudiesAged, 80 and overAntineoplastic Combined Chemotherapy Protocols

Stichwörter der Autor:innen

DNA prognosisT‐cell lymphomahaematological malignanciesprognostic factors

Substanzen

Cell-Free Nucleic AcidsBiomarkers, Tumor

Autor:innen und Institutionen

  • University of Milan, Milan, Italy.
  • Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Unit of Biostatistics for Clinical Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Division of Hematology, Azienda Ospedaliera e Universitaria Città della Salute e della Scienza, Turin, Italy.
  • Hematology Division, ASST Spedali Civili di Brescia, Brescia, Italy.
  • Hematology Unit, Ospedale Oncologico Armando Businco, Cagliari, Italy.

ORCID-Profile: E Fardella, A Chiappella, A Pinto, C Carniti, P Corradini

Förderung

  • Associazione Italiana per la Ricerca sul Cancro
  • Associazione Italiana Contro le Leucemie - Linfomi e Mieloma

Zitieren

APA

Fardella, E., Zanirato, G., Magni, M., Caldarelli, N., Chiappella, A., Dodero, A., Ljevar, S., Orsucci, L., Re, A., Usai, S. V., Stefoni, V., Castellino, C., Rossi, F. G., Pinto, A., Carniti, C., & Corradini, P. (2024). Prognostic impact of pretreatment cell‐free DNA concentration in newly diagnosed peripheral T‐cell lymphomas. British Journal of Haematology. https://doi.org/10.1111/bjh.19280

Vancouver

Fardella E, Zanirato G, Magni M, Caldarelli N, Chiappella A, Dodero A, et al. Prognostic impact of pretreatment cell‐free DNA concentration in newly diagnosed peripheral T‐cell lymphomas. British Journal of Haematology. 2024. doi:10.1111/bjh.19280

BibTeX
@article{Fardella2024,
  author = {Fardella, E and Zanirato, G and Magni, M and Caldarelli, N and Chiappella, A and Dodero, A and Ljevar, S and Orsucci, L and Re, A and Usai, S V and Stefoni, V and Castellino, C and Rossi, F G and Pinto, A and Carniti, C and Corradini, P},
  title = {Prognostic impact of pretreatment cell‐free DNA concentration in newly diagnosed peripheral T‐cell lymphomas},
  journal = {British Journal of Haematology},
  year = {2024},
  doi = {10.1111/bjh.19280}
}
Kostenlos starten →